Analysis of heavy oils: Method development and application to Cerro Negro heavy petroleum

On March 6, 1980, the US Department of Energy (DOE) and the Ministry of Energy and Mines of Venezuela (MEMV) entered into a joint agreement which included analysis of heavy crude oils from the Venezuelan Orinoco oil belt.The purpose of this report is to present compositional data and describe new analytical methods obtained from work on the Cerro Negro Orinoco belt crude oil since 1980. Most of the chapters focus on the methods rather than the resulting data on Cerro Negro oil, and results from other oils obtained during the verification of the method are included. In addition, published work on analysis of heavy oils, tar sand bitumens, and like materials is reviewed, and the overall state of the art in analytical methodology for heavy fossil liquids is assessed. The various phases of the work included: distillation and determination of routine'' physical/chemical properties (Chapter 1); preliminary separation of >200{degree}C distillates and the residue into acid, base, neutral, saturated hydrocarbon and neutral-aromatic concentrates (Chapter 2); further separation of acid, base, and neutral concentrates into subtypes (Chapters 3-5); and determination of the distribution of metal-containing compounds in all fractions (Chapter 6)

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-\u3b2 Superfamily

We present an integromic analysis of gene alterations that modulate transforming growth factor \u3b2 (TGF-\u3b2)-Smad-mediated signaling in 9,125 tumor samples across 33 cancer types in The Cancer Genome Atlas (TCGA). Focusing on genes that encode mediators and regulators of TGF-\u3b2 signaling, we found at least one genomic alteration (mutation, homozygous deletion, or amplification) in 39% of samples, with highest frequencies in gastrointestinal cancers. We identified mutation hotspots in genes that encode TGF-\u3b2 ligands (BMP5), receptors (TGFBR2, AVCR2A, and BMPR2), and Smads (SMAD2 and SMAD4). Alterations in the TGF-\u3b2 superfamily correlated positively with expression of metastasis-associated genes and with decreased survival. Correlation analyses showed the contributions of mutation, amplification, deletion, DNA methylation, and miRNA expression to transcriptional activity of TGF-\u3b2 signaling in each cancer type. This study provides a broad molecular perspective relevant for future functional and therapeutic studies of the diverse cancer pathways mediated by the TGF-\u3b2 superfamily. To date, there are no studies of the TGF-\u3b2 superfamily of signaling pathways across multiple cancers. This study represents a key starting point for unraveling the role of this complex superfamily in 33 divergent cancer types from over 9,000 patients